2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer
Join Karen Lisa Smith, MD, MPH, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as she presents Updates in the Management of Breast Cancer as part of the NCCN 2017 Oncology Case Manager and Medical Director Program Webinar Series.
Breast cancer is second only to lung cancer as a cause of cancer death. The American Cancer Society has estimated 255,180 will be diagnosed and 41,070 will die of breast cancer in the United States in 2017. The clinical diagnosis and management of patients with breast cancer are complex and varied and continuously evolving. It is important to understand the overview of management of both localized as well as advanced breast cancer and also learn about the recent advances in management to coordinate optimal care.
The treatment decision-making process should involve a detailed discussion of the benefits and risks associated with all possible treatment strategies. Most often, case managers oversee a patient’s care throughout diagnosis, treatment, and recovery. In order to help their patients navigate through the tests and treatments, it is essential for case managers to stay up-to-date on currently available and emerging evidence-based approaches for the management of breast cancer. By staying up-to-date with the recent advances in breast cancer management, case managers can help patients get through the complexities of the treatment plan, get quicker responses to important questions, help manage treatment-related crises, and connect the patient and family to appropriate resources and help patients achieve cost-effective and high-quality care.
This program is designed to meet the educational needs of case managers, nurses in other roles (i.e., quality management and utilization review), medical directors at managed care organizations, reinsurers, TPAs, and case management and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care and/or make coverage decisions. Programs may also be of interest to nurses, nurse navigators/care coordinators, and physicians who work directly with patients in clinical settings as well as clinical pharmacists in managed care organizations and other settings.
Following this activity, participants should be able to:
- Provide caregivers and patients with localized breast cancer information about all available treatment options and discuss benefits versus harms for informed shared-decision making.
- Explain the role of available genomic assays in decision-making regarding adjuvant chemotherapy and extended adjuvant endocrine therapy.
- Describe the advances in systemic therapy options for patients with advanced breast cancer.
Karen Lisa Smith, MD, MPH
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NCCN designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 hours of Category I credits for completing this activity.
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NCCN designates this educational activity for a maximum of 1.25 contact hours.
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. This course is approved for 1.25 CE contact hours. Activity Code: I00028897; Approval #: 170003903
|National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN: 0836-0000-17-111-L01-P
- 1.25 ACPE contact hours
- 1.25 AMA PRA Category 1 Credit™
- 1.25 ANCC contact hours
- 1.25 CCM clock hours
- 1.25 Participation
Click the Take Course button to register for this live webinar.
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing